Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
- Referrals to patient-related programs or resources
- Donations, website, or event-related assistance
- Tobacco-related topics
- Volunteer opportunities
- Cancer Information
For medical questions, we encourage you to review our information with your doctor.
Pancreatic Neuroendocrine Tumor (NET)
- Surgery for Pancreatic Neuroendocrine Tumor
- Ablation or Embolization Treatments for Pancreatic Neuroendocrine Tumor
- Radiation Therapy for Pancreatic Neuroendocrine Tumor
- Chemotherapy for Pancreatic Neuroendocrine Tumor
- Targeted Drug Therapy for Pancreatic Neuroendocrine Tumor
- Other Drugs for Pancreatic Neuroendocrine Tumors
- Treating Pancreatic Neuroendocrine Tumor, Based on Extent of the Tumor
- If You Have a Pancreatic Neuroendocrine Tumor (NET)
Pancreatic Neuroendocrine Tumor Risk Factors
A risk factor is anything that increases your chance of getting a disease such as cancer. Different cancers have different risk factors. Some risk factors, like smoking, can be changed. Others, like a person’s age or family history, can’t be changed.
But having a risk factor, or even many risk factors, does not mean that you will get the disease. And some people who get the disease may have few or no known risk factors.
Several factors can affect a person’s chance of getting a neuroendocrine tumor (NET) of the pancreas.
Risk factors that can be changed
Smoking
Smoking is a risk factor for pancreatic NETs. Most research shows that heavy smoking increases risk, but some studies show that any history of smoking could put you at risk.
Alcohol
Some studies have shown a link between heavy alcohol use and pancreatic NETs. This link appears to be mostly related to functioning pancreatic NETs rather than nonfunctioning pancreatic NETs. Heavy alcohol use can also lead to conditions such as chronic pancreatitis, which may increase pancreatic NET risk.
Risk factors that can’t be changed
Family history
Pancreatic NETs seem to run in some families. In some of these families, the high risk is due to an inherited syndrome (explained below). In other families, the gene causing the increased risk is not known. If family history is a risk factor, it usually involves a first degree relative (parent, sibling, child), a family history of pancreatic NET, or a family history of any cancer.
Inherited genetic syndromes
Inherited gene changes (mutations) can be passed from parent to child. Sometimes these changes result in syndromes that include increased risks of other cancers (or other health problems).
Pancreatic neuroendocrine tumors and cancers can also be caused by genetic syndromes, such as:
- Neurofibromatosis, type 1, which is caused by mutations in the NF1 gene. This syndrome leads to an increased risk of many tumors, including somatostatinomas.
- Multiple endocrine neoplasia, type I (MEN1), caused by mutations in the MEN1 gene. This syndrome leads to an increased risk of tumors of the parathyroid gland, the pituitary gland, and the islet cells of the pancreas.
- Von Hippel-Lindau (VHL) syndrome, which is caused by mutations in the VHL gene. This syndrome leads to an increased risk of many tumors, including pancreatic NETs.
Changes in the genes that cause some of these syndromes can be found by genetic testing. For more information on genetic testing, see Can Pancreatic Neuroendocrine Tumor Be Found Early?
Diabetes
Pancreatic NETs are more common in people with diabetes. The reason for this is not known. Most of the risk is found in people with type 2 diabetes. This type of diabetes most often starts in adulthood and is often related to being overweight or obese. It’s not clear if people with type 1 (juvenile) diabetes have a higher risk.
Chronic pancreatitis
Chronic pancreatitis, a long-term inflammation of the pancreas, is linked with an increased risk of pancreatic NETs. If chronic pancreatitis is because of heavy alcohol use, then stopping alcohol may help decrease the risk of pancreatic NETs.
Factors with unclear effect on risk
Being overweight or obese
Being overweight or obese could be a risk factor for pancreatic NET. Studies so far are inconclusive.
Coffee
Some older studies have suggested that drinking coffee might increase the risk of pancreatic NET, but more recent studies have not confirmed this.
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as editors and translators with extensive experience in medical writing.
Ben Q, Zhong J, Fei J, et al. Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors: A Case-Control Study. Scientific Reports. 2016;6:36073. doi:10.1038/srep36073.
American Society of Clinical Oncology. Von Hippel-Lindau Syndrome. Accessed at cancer.net. Content is no longer available.
Haugvik SP, Hedenström P, Korsæth E, et al. Diabetes, smoking, alcohol use, and family history of cancer as risk factors for pancreatic neuroendocrine tumors: a systematic review and meta-analysis. Neuroendocrinology. 2015;101(2):133-42. doi: 10.1159/000375164. Epub 2015 Jan 22.
Leoncini E, Carioli G, La Vecchia C, Boccia S, Rindi G. Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis. Ann Oncol. 2016 Jan;27(1):68-81. doi: 10.1093/annonc/mdv505. Epub 2015 Oct 20.
National Cancer Institute. Physician Data Query (PDQ). Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment – Patient Version. 2018. Accessed at https://www.cancer.gov/types/pancreatic/patient/pnet-treatment-pdq on October 7, 2018.
Valente R, Hayes AJ, Haugvik SP, et al. Risk and protective factors for the occurrence of sporadic pancreatic endocrine neoplasms. Endocr Relat Cancer. 2017 Aug;24(8):405-414. doi: 10.1530/ERC-17-0040. Epub 2017 May 31.
Vinik A, Perry RR, Hughes MS, et al. Multiple Endocrine Neoplasia Type 1. [Updated 2017 Oct 7]. In: De Groot LJ, Chrousos G, Dungan K, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK481897/. Accessed October 9, 2018.
Last Revised: October 30, 2018
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
American Cancer Society Emails
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.